韩国Jeil Pharma安装的无菌测试隔离器

一组无菌测试隔离系统安装在2017年12月的韩国的Jeil Pharma。

脂肪于2017年11月17日在杭州市工厂完成。

Jeil Pharma非常满足于系统的性能。根据韩国FDA通过IQ和OQ。

这是韩国六际无菌测试隔离系统的首次安装。我们的团队通过运营该项目学习KGMP和KFDA规定。

我们非常感谢我们的最终用户Jeil Pharma＆韩国市场分销商Kosa Bio Inc.

作为独家销售机构，安提进科技将为滑动客户提供国际标准隔离器解决方案。

关于Jeil Pharma：

1959年成立于1959年，自1988年以来已在KOPI上市。截至2010年，JEIL由961名员工构成，销售额达到4313亿令人朝上。中央研发中心成立于1980年，形成了注册日志的研发活动的核心。目前，截至2010年，新的药物开发研究实验室，综合研究实验室和制剂研究实验室正在积极参与进入创新新药，渐进式修饰的药物和仿制药的完整制造和成分的研究。Jeil’s factory located in Yongin-si, Gyeonggi-do, Korea which was established in 1986 was accredited as fulfilling KGMP in 1987, and produces solid medicines and injections, finished pharmaceutical products including patches, and Active Pharmaceutical Ingredients(APIs) such as anti-biotic ingredients, etc. A new factory with the most up-to-dated facilities which comply with EU-GMP and US-GMP is currently under construction, and is scheduled to be completed in the 4th quarter of 2012. Jeil, equipped with global-class research centers and production facilities, has been recognized for its outstanding value on the world market as well. In the ingredients sector, Jeil exports synthetic ingredients such as Cefditoren Pivoxil, Epinastine HCl, etc. to locations including Japan and China, while also exporting finished products such as Kefentech Plaster (Ketoprofen), Cilapenem Injection (Imipenem / Cilastatin Sodium), etc. to around 30 countries in ASEAN, Central and South America, Africa, etc.